Volume 12, Issue 4 (Jul & Aug 2022)                   J Research Health 2022, 12(4): 215-218 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mousavi M R, Besharatpour M. Identification of Patients With Schizophrenia: Immediate Action to Control COVID-19 Pandemic in Iran. J Research Health 2022; 12 (4) :215-218
URL: http://jrh.gmu.ac.ir/article-1-2073-en.html
Identification of Patients With Schizophrenia: Immediate Action to Control COVID-19 Pandemic in Iran
Mohammad Reza Mousavi 1, Mahboobeh Besharatpour2
1- Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran. , mr.mousavi@hotmail.com
2- Department of Epidemiology, Faculty of Health and Safety, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Abstract:   (860 Views)
The characteristics of schizophrenia, including delusions, hallucinations, poor insight, cognitive impairment, and disorganized behavior [1] and demographic characteristics including homelessness and living in communal homes [1] have provided the basis for COVID-19 infection in patients with schizophrenia. Due to impairments in insight and decision-making capacity, people with schizophrenia are less likely to adhere to protective measures [2].
 
Keywords: Schizophrenia, COVID -19 pandemic, Iran
Full-Text [PDF 401 kb]   (272 Downloads) |   |   Full-Text (HTML)  (167 Views)  
Type of Study: Viewpoint | Subject: ● International Health
Received: 2022/04/9 | Accepted: 2022/06/18 | Published: 2022/07/1
Add your comments about this article : Your username or Email:
CAPTCHA
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Research and Health

Designed & Developed by : Yektaweb